HealthEquity (HQY) Misses Q4 EPS by 3c, provides guidance

HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.69, $0.03 worse than the analyst estimate of $0.72. Revenue for the quarter came in at $311.8 million versus the consensus estimate of $305.82 million.

GUIDANCE:

HealthEquity sees FY2026 EPS of $3.54-$3.74, versus the consensus of $3.76. HealthEquity sees FY2026 revenue of $1.28-1.305 billion, versus the consensus of $1.309 billion.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Genco Shipping & Trading Limited (GNK) 8400 contracts of August 30 calls trade, share price up 5.5%